The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis

Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254 Miller, 2016, Cancer treatment and survivorship statistics, 2016, CA Cancer J Clin, 66, 271, 10.3322/caac.21349 Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, New Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Chen, 2016, Cancer statistics in China, 2015, CA Cancer J Clin, 66, 115, 10.3322/caac.21338 Chaffer, 2011, A perspective on cancer cell metastasis, Science, 331, 1559, 10.1126/science.1203543 Cai, 2015, Accessing Genetic Information with Liquid Biopsies, Trends Genet, 31, 564, 10.1016/j.tig.2015.06.001 Alix-Panabieres, 2013, Circulating tumor cells: liquid biopsy of cancer, Clin Chem, 59, 110, 10.1373/clinchem.2012.194258 Haber, 2014, Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA, Cancer Discov, 4, 650, 10.1158/2159-8290.CD-13-1014 Kalluri, 2009, The basics of epithelial-mesenchymal transition, J Clin Invest, 119, 1420, 10.1172/JCI39104 Welinder, 2015, Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer, Cancer Lett, 358, 43, 10.1016/j.canlet.2014.12.024 Sastre, 2008, Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables, Ann Oncol, 19, 935, 10.1093/annonc/mdm583 Thorsteinsson, 2011, Low number of detectable circulating tumor cells in non-metastatic colon cancer, Anticancer Res, 31, 613 Cohen, 2009, Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer, Ann Oncol, 20, 1223, 10.1093/annonc/mdn786 Tol, 2010, Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents, Ann Oncol, 21, 1006, 10.1093/annonc/mdp463 Tsai, 2015, Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients, Sci Rep, 6, 24517, 10.1038/srep24517 Bork, 2015, Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study, Br J Cancer, 112, 1306, 10.1038/bjc.2015.88 Sotelo, 2015, Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer, Ann Oncol, 26, 535, 10.1093/annonc/mdu568 Hinz, 2015, Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer, BMC Cancer, 15, 953, 10.1186/s12885-015-1989-z Vlems, 2003, Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer, Br J Surg, 90, 989, 10.1002/bjs.4161 Galizia, 2013, Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients, J Gastrointest Surg, 17, 1809, 10.1007/s11605-013-2258-6 Matsusaka, 2011, Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer, Cancer Sci, 102, 1188, 10.1111/j.1349-7006.2011.01926.x Wells GA, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL]. [2013-11-26]. Available from: http://www.ohri.ca/programs/clinical epidemiology/oxford.asp. Aggarwal, 2013, Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer, Ann Oncol, 24, 420, 10.1093/annonc/mds336 Gazzaniga, 2013, Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?, J Cancer Res Clin, 139, 1411, 10.1007/s00432-013-1450-0 Barbazán, 2014, A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer, Int J Cancer, 135, 2633, 10.1002/ijc.28910 Kuboki, 2013, Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer, Anticancer Res, 33, 3905 Seeberg, 2015, Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival, Ann Surg, 261, 164, 10.1097/SLA.0000000000000580 Sastre, 2013, Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab, Clin Colorectal Cancer, 12, 280, 10.1016/j.clcc.2013.06.001 Lu, 2013, Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer, Br J Cancer, 108, 791, 10.1038/bjc.2012.595 Ning, 2015, Cytokeratin-20 and survivin-expressing circulating tumor cells predict survival in metastatic colorectal cancer patients by a combined immunomagnetic qRT-PCR approach, Mol Cancer Ther, 14, 2401, 10.1158/1535-7163.MCT-15-0359 Hiraiwa, 2008, Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers, Ann Surg Oncol, 15, 3092, 10.1245/s10434-008-0122-9 Romiti, 2014, Circulating tumor cells count predicts survival in colorectal cancer patients, J Gastrointest Liver Dis, 23, 279, 10.15403/jgld.2014.1121.233.arom1 Fan, 2009, Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer, Gynecol Oncol, 112, 185, 10.1016/j.ygyno.2008.09.021 Yokobori, 2013, Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis, Cancer Res, 73, 2059, 10.1158/0008-5472.CAN-12-0326 Pantel, 2010, Circulating tumour cells in cancer patients: challenges and perspectives, Trends Mol Med, 16, 398, 10.1016/j.molmed.2010.07.001 Wicha, 2011, Circulating tumor cells: not all detected cells are bad and not all bad cells are detected, J Clin Oncol, 29, 1508, 10.1200/JCO.2010.34.0026 Paoletti, 2015, Significance of circulating tumor cells in metastatic triple-negative breast cancer patients within a randomized, phase II trial: TBCRC 019, Clin Cancer Res, 21, 2771, 10.1158/1078-0432.CCR-14-2781 Pearl, 2014, Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer, Gynecol Oncol, 134, 581, 10.1016/j.ygyno.2014.06.013 Goldkorn, 2014, Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer, J Clin Oncol, 32, 1136, 10.1200/JCO.2013.51.7417 Hiltermann, 2012, Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor, Ann Oncol, 23, 2937, 10.1093/annonc/mds138 Matsushita, 2015, Clinical significance of circulating tumor cells in peripheral blood of patients with esophageal squamous cell carcinoma, Ann Surg Oncol, 22, 3674, 10.1245/s10434-015-4392-8 Karhade, 2014, Circulating tumor cells in non-metastatic triple-negative breast cancer, Breast Cancer Res Treat, 147, 325, 10.1007/s10549-014-3103-7